Skip to main content
. 2020 May 19;86(11):e00242-20. doi: 10.1128/AEM.00242-20

TABLE 2.

Strains and plasmids used in this study

Strain, mutant, or plasmid Descriptiona Reference or source
E. coli strain
    DH5α Strain used for gene cloning TaKaRa
C. hutchinsonii strains
    ATCC 33406 Wild type ATCC
        ΔgldN chu_0174 deleted This study
        Δ2610 chu_2610 deleted This study
        C0174 Complementation of ΔgldN with pHB0174 This study
        Δ2807 chu_2807 deleted This study
        Δ0344 chu_0344 deleted 20
        Δ0052 chu_0052 deleted Unpublished data
        Δ0007 chu_0007 deleted This study
        Δ3384 chu_3384 deleted This study
        Δ3732 chu_3732 deleted 41
Plasmids
    pCFX Gene deletion template plasmid carrying cfxA flanked by two MCS; Apr (Cfxr); derived from pCFXSK with removal of the FRT sites This study
    pTSKQ Gene deletion template plasmid carrying ermF flanked by two MCS; Apr (Emr); derived from pTSK with removal of the FRT sites This study
    pTKS Gene deletion template plasmid carrying ermF flanked by two MCS; Apr (Emr) 20
    pSJHS Gene deletion template plasmid carrying ermF flanked by two MCS; Apr (Emr) 20
    pSKSO8TG Used for complementation of the mutants in C. hutchinsonii with oriC; Apr (Emr) 20
    pHB0174 Plasmid constructed from pSKSO8TG used for complementation of ΔgldN; Apr (Emr) This study
    pHB2807 Plasmid constructed from pSKSO8TG used for complementation of Δ2807; Apr (Emr) This study
a

MCS, multiple cloning site(s); FRT, FLP recombination target; Apr, ampicillin resistance; Cfxr, cefoxitin resistance; Emr, erythromycin resistance. Phenotypes in parentheses are expressed in C. hutchinsonii, and phenotypes not in parentheses are expressed in E. coli.